- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Walpar Nutritions reported **₹79.32 Cr** total revenue for FY26, a **9.9% YoY increase**, from its Pharmaceutical, Nutraceutical, Herbal, and Ayurvedic segments. Net profit for FY26 was **₹2.92 Cr**, a **24.7% YoY decline** from ₹3.88 Cr, primarily due to higher tax expenses. Basic EPS was ₹3.10. While material and other costs saw reductions, higher finance costs and increased tax outflow impacted overall profitability despite revenue growth. These results indicate mixed financial momentum, with robust revenue growth overshadowed by a dip in net profit.